{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:37:00Z","timestamp":1787683020487,"version":"build-2784847793"},"reference-count":33,"publisher":"American Veterinary Medical Association (AVMA)","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec id=\"sc_a1\">\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>The aim of this study was to investigate whether plasma neurofilament light chain (pNfL) concentration was altered in Labrador Retrievers with idiopathic laryngeal paralysis (ILP) compared to a control population. A secondary aim was to investigate relationships between age, height, weight, and body mass index in the populations studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a2\">\n<jats:title>ANIMALS<\/jats:title>\n<jats:p>123 dogs: 62 purebred Labrador Retrievers with ILP (ILP Cases) and 61 age-matched healthy medium- to large-breed dogs (Controls).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a3\">\n<jats:title>METHODS<\/jats:title>\n<jats:p>Dogs, recruited from August 1, 2016, to March 1, 2022, were categorized as case or control based on a combination of physical exam, neurologic exam, and history. Blood plasma was collected, and pNfL concentration was measured. pNfL concentrations were compared between ILP Cases and Controls. Covariables including age, height, and weight were collected. Relationships between pNfL and covariables were analyzed within and between groups. In dogs where 2 plasma samples were available from differing time points, pNfL concentrations were measured to evaluate alterations over time.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a4\">\n<jats:title>RESULTS<\/jats:title>\n<jats:p>No significant difference in pNfL concentration was found between ILP Cases and Control (<jats:italic>P<\/jats:italic> = .36). pNfL concentrations had moderate negative correlations with weight and height in the Control group; other variables did not correlate with pNfL concentrations in ILP Case or Control groups. pNfL concentrations do not correlate with ILP disease status or duration in Labrador Retrievers.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sc_a5\">\n<jats:title>CLINICAL RELEVANCE<\/jats:title>\n<jats:p>There is no evidence that pNfL levels are altered due to ILP disease duration or progression when compared with healthy controls. When evaluating pNfL concentrations in the dog, weight and height should be considered.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/ajvr.23.12.0292","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T13:19:34Z","timestamp":1708435174000},"source":"Crossref","is-referenced-by-count":1,"title":["Neurofilament light chain concentration does not correlate with disease status in Labrador Retrievers affected with idiopathic laryngeal paralysis"],"prefix":"10.2460","volume":"85","author":[{"given":"Jacquelyn H.","family":"Perino","sequence":"first","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Patterson","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Momen","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Borisova","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK"},{"name":"UK Dementia Research Institute, University College of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Heslegrave","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK"},{"name":"UK Dementia Research Institute, University College of London, London, UK"},{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK"},{"name":"UK Dementia Research Institute, University College of London, London, UK"},{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Gruel","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Binversie","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Rylander","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Starr","family":"Cameron","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Miranda","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi","family":"Conidi","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Svaren","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah J.","family":"Sample","sequence":"additional","affiliation":[{"name":"Comparative Genetic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"3","key":"B1","series-title":"Vet Medicine Sci","first-page":"306","article-title":"Late-onset laryngeal paralysis: 0wner perception of quality of life and cause of death","volume":"6","author":"Sample SJ","year":"2020","unstructured":"Sample SJ, Stilin A, Binversie EE, Baker LA, Hardie RJ. Late-onset laryngeal paralysis: 0wner perception of quality of life and cause of death. Vet Medicine Sci. 2020;6(3):306\u2013313. doi:10.1002\/vms3.240"},{"issue":"3","key":"B2","series-title":"J Am Anim Hosp Assoc","first-page":"161","article-title":"Histopathological confirmation of polyneuropathy in 11 dogs with laryngeal paralysis","volume":"46","author":"Thieman KM","year":"2010","unstructured":"Thieman KM, Krahwinkel DJ, Sims MH, Shelton GD. Histopathological confirmation of polyneuropathy in 11 dogs with laryngeal paralysis. J Am Anim Hosp Assoc. 2010;46(3):161 167. doi:10.5326\/0460161"},{"issue":"3","key":"B3","series-title":"Vet J","first-page":"274","article-title":"Canine inherited motor and sensory neuropathies: an updated classification in 22 breeds and comparison to Charcot-Marie-Tooth disease","volume":"188","author":"Granger N","year":"2011","unstructured":"Granger N. Canine inherited motor and sensory neuropathies: an updated classification in 22 breeds and comparison to Charcot-Marie-Tooth disease. Vet J. 2011;188(3):274 285. doi:10.1016\/j.tvjl.2010.06.003"},{"issue":"2","key":"B4","series-title":"Vet Surg","first-page":"139","article-title":"Esophageal dysfunction in dogs with idiopathic laryngeal paralysis: a controlled cohort study","volume":"39","author":"Stanley BJ","year":"2010","unstructured":"Stanley BJ, Hauptman JG, Fritz MC, Rosenstein DS, Kinns J. Esophageal dysfunction in dogs with idiopathic laryngeal paralysis: a controlled cohort study. Vet Surg. 2010;39(2):139 149. doi:10.1111\/j.1532-950x.2009.00626.x"},{"issue":"12","key":"B5","series-title":"Genes (Basel)","first-page":"1426","article-title":"A CNTNAP1 missense variant is associated with canine laryngeal paralysis and polyneuropathy","volume":"11","author":"Letko A","year":"2020","unstructured":"Letko A, Minor KM, Friedenberg SG, et al. A CNTNAP1 missense variant is associated with canine laryngeal paralysis and polyneuropathy. Genes (Basel) 2020;11(12):1426. doi:10.3390\/genes11121426"},{"issue":"2","key":"B6","series-title":"Vet Clin North Am Small Animal Pract","first-page":"295","article-title":"Laryngeal disease in dogs and cats an update","volume":"50","author":"MacPhail CM","year":"2020","unstructured":"MacPhail CM. Laryngeal disease in dogs and cats an update. Vet Clin North Am Small Animal Pract. 2020;50(2):295\u2013310. doi:10.1016\/j.cvsm.2019.11.001"},{"issue":"2","key":"B7","series-title":"Vet Surg","first-page":"254","article-title":"Idiopathic canine laryngeal paralysis as one sign of a diffuse polyneuropathy: an observational study of 90 cases (2007\u20132013)","volume":"45","author":"Bookbinder LC","year":"2016","unstructured":"Bookbinder LC, Flanders J, Barry JS, Cheetham J. Idiopathic canine laryngeal paralysis as one sign of a diffuse polyneuropathy: an observational study of 90 cases (2007\u20132013). Vet Surg. 2016;45(2):254 260. doi:10.1111\/vsu.12444"},{"issue":"11","key":"B8","series-title":"Mol Neurobiol","first-page":"4667","article-title":"Different clinical contexts of use of blood neurofilament light chain protein in the spectrum of neurodegenerative diseases","volume":"57","author":"Palermo G","year":"2020","unstructured":"Palermo G, Mazzucchi S, Vecchia AD, et al. Different clinical contexts of use of blood neurofilament light chain protein in the spectrum of neurodegenerative diseases. Mol Neurobiol. 2020;57(11):4667\u20134691. doi:10.1007\/s12035-020-02035-9"},{"issue":"4","key":"B9","series-title":"Csh Perspect Biol","first-page":"a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan A","year":"2017","unstructured":"Yuan A, Rao MV, Veeranna, Nixon RA. Neurofilaments and neurofilament proteins in health and disease. Csh Perspect Biol. 2017;9(4):a018309. doi:10.1101\/cshperspect.a018309"},{"issue":"1","key":"B10","series-title":"Sci Rep","first-page":"11034","article-title":"Seven day pre-analytical stability of serum and plasma neurofilament light chain","volume":"11","author":"Altmann P","year":"2021","unstructured":"Altmann P, Ponleitner M, Rommer PS, et al. Seven day pre-analytical stability of serum and plasma neurofilament light chain. Sci Rep. 2021;11(1):11034. doi:10.1038\/s41598-021-90639-z"},{"issue":"4","key":"B11","series-title":"J Alzheimer's Dis","first-page":"1353","article-title":"Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis","volume":"72","author":"Wang SY","year":"2019","unstructured":"Wang SY, Chen W, Xu W, et al. Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis. J Alzheimer's Dis. 2019;72(4):1353\u20131361. doi:10.3233\/jad-190615"},{"issue":"2","key":"B12","series-title":"J Neurology Neurosurg Psychiatry","first-page":"157","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde F","year":"2018","unstructured":"Verde F, Steinacker P, Weishaupt JH, et al. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J Neurology Neurosurg Psychiatry. 2018;90(2):157\u2013164. doi:10.1136\/jnnp-2018-318704"},{"issue":"10","key":"B13","series-title":"Neurology","first-page":"e1007","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle J","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019;92(10):e1007\u2013e1015. doi:10.1212\/wnl.0000000000007032"},{"issue":"3","key":"B14","series-title":"Eur J Neurol","first-page":"974","article-title":"Plasma neurofilament light chain as a potential biomarker in Charcot-Marie-Tooth disease","volume":"28","author":"Millere E","year":"2021","unstructured":"Millere E, Rots D, Simr\u00e9n J, et al. Plasma neurofilament light chain as a potential biomarker in Charcot-Marie-Tooth disease. Eur J Neurol. 2021;28(3):974\u2013981. doi:10.1111\/ene.14689"},{"issue":"7","key":"B15","series-title":"Mol Neurobiol","first-page":"3143","article-title":"Plasma neurofilament light chain as a translational biomarker of aging and neurodegeneration in dogs","volume":"57","author":"Panek WK","year":"2020","unstructured":"Panek WK, Gruen ME, Murdoch DM, et al. Plasma neurofilament light chain as a translational biomarker of aging and neurodegeneration in dogs. Mol Neurobiol. 2020;57(7):3143\u20133149. doi:10.1007\/s12035-020-01951-0"},{"key":"B16","series-title":"Neurosci Lett","first-page":"135593","article-title":"Neurofilament light plasma concentration positively associates with age and negatively associates with weight and height in the dog","volume":"744","author":"Perino J","year":"2021","unstructured":"Perino J, Patterson M, Momen M, et al. Neurofilament light plasma concentration positively associates with age and negatively associates with weight and height in the dog. Neurosci Lett. 2021;744:135593. doi:10.1016\/j.neulet.2020.135593"},{"key":"B17","article-title":"Dog breeds","unstructured":"American Kennel Club. Dog breeds. Accessed December 14, 2022. https:\/\/www.akc.org\/dog-breeds\/"},{"issue":"3","key":"B18","series-title":"Am J Vet Res","first-page":"330","article-title":"Comparison of two canine registry databases on the prevalence of hip dysplasia by breed and the relationship of dysplasia with body weight and height","volume":"69","author":"Comhaire FH","year":"2008","unstructured":"Comhaire FH, Snaps F. Comparison of two canine registry databases on the prevalence of hip dysplasia by breed and the relationship of dysplasia with body weight and height. Am J Vet Res. 2008;69(3):330\u2013333. doi:10.2460\/ajvr.69.3.330"},{"key":"B19","year":"2021","unstructured":"R Core Team. The R Project for Statistical Computing. The R Foundation; 2021. Accessed July 28, 2022. https:\/\/www.R-project.org\/"},{"key":"B20","unstructured":"GraphPad Prism. GraphPad Software. Accessed January 22, 2023. www.graphpad.com"},{"issue":"8","key":"B21","series-title":"J Neurology Neurosurg Psychiatry","first-page":"870","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani L","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Filippo MD, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurology Neurosurg Psychiatry. 2019;90(8):870\u2013881. doi:10.1136\/jnnp-2018-320106"},{"issue":"3","key":"B22","series-title":"JAMA Neurol","first-page":"318","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson B","year":"2019","unstructured":"Olsson B, Portelius E, Cullen NC, et al. Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders. JAMA Neurol. 2019;76(3):318. doi:10.1001\/jamaneurol.2018.3746"},{"key":"B23","series-title":"Handb Clin Neurol","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/B978-0-444-64076-5.00042-9","article-title":"Chapter 42 \u2013 Neuropathy","volume":"148","author":"Pisciotta C","year":"2018","unstructured":"Pisciotta C, Shy ME. Chapter 42 \u2013 Neuropathy. Handb Clin Neurol. 2018;148:653\u2013665. doi:10.1016\/b978-0-444-64076-5.00042-9"},{"issue":"6","key":"B24","series-title":"Neurology","first-page":"e518","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius \u00c5","year":"2018","unstructured":"Sandelius \u00c5, Zetterberg H, Blennow K, et al. Plasma neurofilament light chain concentration in the inherited peripheral neuropathies. Neurology. 2018;90(6):e518 e524. doi:10.1212\/wnl.0000000000004932"},{"issue":"1","key":"B25","series-title":"J Peripher Nerv Syst","first-page":"50","article-title":"A longitudinal and cross-sectional study of plasma neurofilament light chain concentration in Charcot-Marie-Tooth disease","volume":"27","author":"Rossor AM","year":"2022","unstructured":"Rossor AM, Kapoor M, Wellington H, et al. A longitudinal and cross-sectional study of plasma neurofilament light chain concentration in Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2022;27(1):50\u201357. doi:10.1111\/jns.12477"},{"issue":"8","key":"B26","series-title":"Alzheimer's Dement","first-page":"1353","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman AM","year":"2021","unstructured":"Brickman AM, Manly JJ, Honig LS, et al. Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study. Alzheimer's Dement. 2021;17(8):1353\u20131364. doi:10.1002\/alz.12301"},{"issue":"1","key":"B27","series-title":"Alzheimer's Dement","first-page":"36","article-title":"Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: important considerations for clinical trials and practice","volume":"19","author":"O'Bryant SE","year":"2023","unstructured":"O'Bryant SE, Petersen M, Hall J, Johnson LA, HABS-HD Study Team. Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: important considerations for clinical trials and practice. Alzheimer's Dement. 2023;19(1):36\u201343. doi:10.1002\/alz.12647"},{"issue":"1","key":"B28","series-title":"Ann Clin Transl Neurol","first-page":"139","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"7","author":"Manouchehrinia A","year":"2020","unstructured":"Manouchehrinia A, Piehl F, Hillert J, et al. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels. Ann Clin Transl Neurol. 2020;7(1):139\u2013143. doi:10.1002\/acn3.50972"},{"issue":"3","key":"B29","series-title":"Lancet Neurol","first-page":"246","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert P","year":"2022","unstructured":"Benkert P, Meier S, Schaedelin S, et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol. 2022;21(3):246\u2013257. doi:10.1016\/s1474-4422(22)00009-6"},{"issue":"1","key":"B30","series-title":"Alzheimer's Dement Diagn Assess Dis Monit","first-page":"e12315","article-title":"Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI","volume":"14","author":"Windon C","year":"2022","unstructured":"Windon C, Iaccarino L, Mundada N, et al. Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI. Alzheimer's Dement Diagn Assess Dis Monit. 2022;14(1):e12315. doi:10.1002\/dad2.12315"},{"issue":"4","key":"B31","series-title":"Vet Anaesth Analg","first-page":"493","article-title":"Laryngeal function in normal dogs administered isoflurane following partial clearance of alfaxalone or propofol","volume":"48","author":"Kapaldo N","year":"2021","unstructured":"Kapaldo N, McMurphy R, Hodgson D, Roush J, Berke K, Klocke E. Laryngeal function in normal dogs administered isoflurane following partial clearance of alfaxalone or propofol. Vet Anaesth Analg. 2021;48(4):493\u2013500. doi:10.1016\/j.vaa.2021.03.009"},{"issue":"4","key":"B32","series-title":"Vet Anaesth Analg","first-page":"435","article-title":"Effects of chemical and mechanical stimulation on laryngeal motion during alfaxalone, thiopentone or propofol anaesthesia in healthy dogs","volume":"46","author":"Labuscagne S","year":"2019","unstructured":"Labuscagne S, Zeiler GE, Dzikiti BT. Effects of chemical and mechanical stimulation on laryngeal motion during alfaxalone, thiopentone or propofol anaesthesia in healthy dogs. Vet Anaesth Analg. 2019;46(4):435\u2013442. doi:10.1016\/j.vaa.2018.12.010"},{"issue":"3","key":"B33","series-title":"Vet Anaesth Analg","first-page":"241","article-title":"Comparison of the effects of alfaxalone and propofol with acepromazine, butorphanol and\/or doxapram on laryngeal motion and quality of examination in dogs","volume":"45","author":"Radkey DI","year":"2018","unstructured":"Radkey DI, Hardie RJ, Smith LJ. Comparison of the effects of alfaxalone and propofol with acepromazine, butorphanol and\/or doxapram on laryngeal motion and quality of examination in dogs. Vet Anaesth Analg. 2018;45(3):241\u2013249. doi:10.1016\/j.vaa.2017.08.014"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/85\/4\/ajvr.23.12.0292.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/85\/4\/ajvr.23.12.0292.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/85\/4\/ajvr.23.12.0292.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T17:28:50Z","timestamp":1727803730000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/85\/4\/ajvr.23.12.0292.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":33,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.23.12.0292","relation":{},"ISSN":["0002-9645","1943-5681"],"issn-type":[{"value":"0002-9645","type":"print"},{"value":"1943-5681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}